Gansu Longshenrongfa Pharmaceutical Industry Co.,Ltd announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 107.683 million compared to CNY 95.490 million a year ago. Operating loss was CNY 3.617 million compared to CNY 10.609 million a year ago. Net income was CNY 293,520.82 compared to net loss of CNY 10.540 million a year ago. Basic earnings per share from continuing operations was CNY 0.001 compared to basic loss per share from continuing operations of CNY 0.0347 a year ago.